ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,378Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 625

$603K Total Retail Price of All Prescriptions

Rank: 133 out of 625

473 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 9,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 460 430 1 2
LEVOTHYROXINE SODIUM 432 400 2 3
LISINOPRIL 409 370 3 5
OMEPRAZOLE 369 326 4 6
FUROSEMIDE 283 269 5 7
AMLODIPINE BESYLATE 276 255 6 1
ZOLPIDEM TARTRATE 241 214 7 13
METOPROLOL TARTRATE 203 177 8 11
POTASSIUM CHLORIDE 200 188 9 19
METOPROLOL SUCCINATE 186 171 10 15
HYDROCODONE-ACETAMINOPHEN 185 184 S3 11 4
ATORVASTATIN CALCIUM 175 168 12 9
PRAVASTATIN SODIUM 172 170 13 8
METFORMIN HCL ER 153 142 14 41
NEXIUM 153 134 14 21
WARFARIN SODIUM 152 140 16 20
CRESTOR 136 95 17 17
HYDROCHLOROTHIAZIDE 131 123 18 12
LOSARTAN POTASSIUM 122 116 19 18
TRAMADOL HCL 116 87 20 16
PAROXETINE HCL 112 78 21 76
DONEPEZIL HCL 106 103 22 33
DIGOXIN 106 106 22 55
SERTRALINE HCL 104 98 24 26
FLUTICASONE PROPIONATE 100 87 25 32
ESCITALOPRAM OXALATE 96 80 26 67
CLOPIDOGREL 94 74 27 30
TAMSULOSIN HCL 93 69 28 36
CITALOPRAM HBR 91 70 29 24
BENAZEPRIL HCL 86 71 30 35
GABAPENTIN 80 70 31 14
ALLOPURINOL 78 49 32 29
ATENOLOL 75 75 33 22
ISOSORBIDE MONONITRATE ER 75 53 33 49
QUINAPRIL HCL 74 71 35 136
DILTIAZEM 24HR CD 74 62 35 131
PLAVIX 74 68 35 43
CLONIDINE HCL 72 47 38 50
ALENDRONATE SODIUM 72 67 38 34
CARVEDILOL 67 60 40 23
PROAIR HFA 64 52 41 57
TRIAMTERENE-HCTZ 63 63 42 53
AMITRIPTYLINE HCL 63 51 R 42 61
SYNTHROID 62 58 44 39
GLIMEPIRIDE 58 58 45 42
TRAZODONE HCL 56 43 46 51
NIFEDIPINE ER 55 47 47 111
GLIPIZIDE ER 55 43 47 68
PREDNISONE 54 53 49 37
RANITIDINE HCL 54 49 49 25
ZOSTAVAX 51 48 51 217
GLIPIZIDE XL 50 50 52 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.